The leading source for credible citizen reporting

Report Your News
Take the tour...

Depomed says shingles pain drug meets study goal

Source: Miami Herald
Menlo Park : CA : USA | about 1 month ago  
Views: 0
Depomed Inc. on Monday reported a successful late stage clinical trial of a drug intended to treat pain following the viral infection shingles, and its shares soared on the news. The company said its DM-1796 significantly reduced post-shingles pain compared to placebo after 10 weeks of treatment....
  • Print
  • Share:
  • Share
  • Digg
  • Reddit
  • Facebook
  • Stumbleupon

Related Allvoices Contributions

News Stories
 
  • News Source: Uinta County News | about 1 month ago
    and its partner XenoPort say they are making progress in development of a strengthened drug to help victims of shingles deal with pain. GSK, which maintains its U.S. headquarters in RTP and employs some 4,000 people in the area, reported Monday that...
  • News Source: Miami Herald | about 1 month ago
    Depomed Inc. on Monday reported a successful late stage clinical trial of a drug intended to treat pain following the viral infection shingles, and its shares soared on the news. The company said its DM-1796 significantly reduced post-shingles pain...
Videos
 >
 
Report Your News Got a similar story?
Add it to the network!

Or add related content to this report

Cell phones Cell phones use report code: @4313054

Most Popular Reports

Contributions

Help and Accounts


Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc 2008-2009. All rights reserved.